Skip to main content

Robert Frank Spurney

Professor of Medicine
Medicine, Nephrology
Duke Box 103015, Durham, NC 27710
Box 103015, Duke University Medical Center, Durham, NC 27710

Selected Grants


U2C/TL1 NC KUH TRIO Administrative Core

ResearchCo Investigator · Awarded by University of North Carolina - Chapel Hill · 2023 - 2028

REGULATORS OF CALCINEURIN PATHWAYS AS DIAGNOSTIC AND THERAPEUTIC TARGETS FOR NEPHROTIC SYNDROME

ResearchInvestigator · Awarded by National Institutes of Health · 2023 - 2026

A Novel Therapeutic Approach to Treat Focal Segmental Glomerulosclerosis (FSGS) R21

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2022 - 2025

Duke Training Grant in Nephrology

Inst. Training Prgm or CMECo-Director · Awarded by National Institutes of Health · 1995 - 2023

Promoting Podocyte Protective Natriuretic Peptide Signaling in Proteinuric Kidney Diseases

ResearchPrincipal Investigator · Awarded by Department of Defense · 2019 - 2022

The Role of Interleukin-15 Receptor-alpha Variants in the Pathogenesis of FSGS

ResearchMentor · Awarded by National Institutes of Health · 2017 - 2022

Transmission electron microscope (TEM)

EquipmentMajor User · Awarded by National Institutes of Health · 2019 - 2021

IPA - Liming Wang

ResearchPrincipal Investigator · Awarded by Durham Veterans Affairs Medical Center · 2019 - 2019

IPA - Robert Griffiths

ResearchPrincipal Investigator · Awarded by Durham Veterans Affairs Medical Center · 2019 - 2019

Targeting TRPC6 to treat focal segmental glomerulosclerosis (FSGS)

ResearchPrincipal Investigator · Awarded by Amgen, Inc. · 2016 - 2019

IPA extension - Cindy Chen

ResearchPrincipal Investigator · Awarded by Durham Veterans Affairs Medical Center · 2019 - 2019

Functional and Phenotypic Characterization of a New FSGS Gene

ResearchCo Investigator · Awarded by National Institutes of Health · 2014 - 2019

IPA extension - Liming Wang

ResearchPrincipal Investigator · Awarded by Durham Veterans Affairs Medical Center · 2018 - 2019

IPA - Cindy Chen

ResearchPrincipal Investigator · Awarded by Durham Veterans Affairs Medical Center · 2018 - 2019

Gene Discovery in Autosomal Dominant Focal Segmental Glomerulosclerosis

ResearchCo Investigator · Awarded by National Institutes of Health · 2012 - 2018

Serial Block Face Scanning Electron Microscope

EquipmentMajor User · Awarded by National Institutes of Health · 2016 - 2018

The role of dendritic cell-mediated T cell activation in hypertension

FellowshipConsultant · Awarded by National Institutes of Health · 2017 - 2017

Role of Gq Signaling in Promoting Podocyte Injury in Diabetes Mellitus

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2011 - 2016

IPA Extensioin - Wang

ResearchPrincipal Investigator · Awarded by Durham Veterans Affairs Medical Center · 2013 - 2014

IPA - Liming Wang

ResearchPrincipal Investigator · Awarded by Durham Veterans Affairs Medical Center · 2011 - 2012

A Novel Mouse Model of Podocyte Injury

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2009 - 2012

Molecular mechanisms of altered calcium sensing in human parathyroid disease

ResearchCollaborating Investigator · Awarded by National Institutes of Health · 2010 - 2012

Regulation of Podocyte Function by Angiotensin II

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2004 - 2008

G-Protein Coupled Receptor Kinases in Osteogenesis

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2001 - 2006

Pharmacologically Induced Neo-osteogenesis

ResearchCo Investigator · Awarded by National Institutes of Health · 1986 - 2004

Thromboxane Receptor Regulation By Protein Kinases

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 1995 - 2000

External Relationships


  • Alnylam Pharmaceutical, Inc.
  • ProteinCure

This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.